US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 2.100
  • +0.180+9.38%
Trading Oct 2 14:14 ET
34.11MMarket Cap-1810P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
17.31%-2.18M
Net income from continuing operations
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
Change In working capital
-98.96%11.05K
62.53%114.83K
-19.02%1.01M
-132.56%-310.15K
-64.99%188.19K
1,323.61%1.06M
145.57%70.65K
783.42%1.25M
159.70%952.46K
138.61%537.5K
-Change in receivables
---51.13K
--129.16K
---129.16K
----
----
--0
--0
--0
----
----
-Change in prepaid assets
-83.28%19.5K
-240.75%-82.13K
424.50%159.18K
-100.07%-54
92.86%-15.78K
-4.84%116.66K
4.48%58.35K
112.30%30.35K
-69.04%72.85K
-18.77%-220.95K
-Change in payables and accrued expense
-95.49%42.68K
451.39%67.8K
-19.46%980.75K
-120.57%-180.94K
-71.20%203.97K
694.05%945.43K
105.83%12.3K
213.88%1.22M
569.04%879.61K
158.71%708.2K
Cash from discontinued investing activities
Operating cash flow
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
17.31%-2.18M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-90.96%320.21K
4.51M
120.92%8.16M
461,963,800.00%4.62M
0
3.54M
0
-75.03%3.7M
-1
3.7M
Net common stock issuance
-90.96%320.21K
--4.3M
60.86%5.94M
----
----
--3.54M
--0
-75.03%3.7M
----
----
Proceeds from stock option exercised by employees
--0
--210.2K
17,069,684.62%2.22M
--2.22M
--0
--73
--0
--13
--0
--13
Cash from discontinued financing activities
Financing cash flow
-90.96%320.21K
--4.51M
120.92%8.16M
461,963,800.00%4.62M
--0
--3.54M
--0
-75.03%3.7M
---1
--3.7M
Net cash flow
Beginning cash position
24.27%8.92M
-17.97%7.47M
-29.69%9.11M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
308.10%12.96M
-26.64%10.61M
-46.82%9.09M
Current changes in cash
-230.15%-2.56M
174.85%1.45M
57.43%-1.64M
128.21%421.86K
-238.17%-2.09M
198.81%1.97M
-3.03%-1.93M
-139.32%-3.85M
0.31%-1.5M
157.47%1.52M
End cash Position
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
Free cash flow
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
17.31%-2.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M17.31%-2.18M
Net income from continuing operations -19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M
Change In working capital -98.96%11.05K62.53%114.83K-19.02%1.01M-132.56%-310.15K-64.99%188.19K1,323.61%1.06M145.57%70.65K783.42%1.25M159.70%952.46K138.61%537.5K
-Change in receivables ---51.13K--129.16K---129.16K----------0--0--0--------
-Change in prepaid assets -83.28%19.5K-240.75%-82.13K424.50%159.18K-100.07%-5492.86%-15.78K-4.84%116.66K4.48%58.35K112.30%30.35K-69.04%72.85K-18.77%-220.95K
-Change in payables and accrued expense -95.49%42.68K451.39%67.8K-19.46%980.75K-120.57%-180.94K-71.20%203.97K694.05%945.43K105.83%12.3K213.88%1.22M569.04%879.61K158.71%708.2K
Cash from discontinued investing activities
Operating cash flow -82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M17.31%-2.18M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -90.96%320.21K4.51M120.92%8.16M461,963,800.00%4.62M03.54M0-75.03%3.7M-13.7M
Net common stock issuance -90.96%320.21K--4.3M60.86%5.94M----------3.54M--0-75.03%3.7M--------
Proceeds from stock option exercised by employees --0--210.2K17,069,684.62%2.22M--2.22M--0--73--0--13--0--13
Cash from discontinued financing activities
Financing cash flow -90.96%320.21K--4.51M120.92%8.16M461,963,800.00%4.62M--0--3.54M--0-75.03%3.7M---1--3.7M
Net cash flow
Beginning cash position 24.27%8.92M-17.97%7.47M-29.69%9.11M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M308.10%12.96M-26.64%10.61M-46.82%9.09M
Current changes in cash -230.15%-2.56M174.85%1.45M57.43%-1.64M128.21%421.86K-238.17%-2.09M198.81%1.97M-3.03%-1.93M-139.32%-3.85M0.31%-1.5M157.47%1.52M
End cash Position -30.45%6.36M24.27%8.92M-17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M
Free cash flow -82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M17.31%-2.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data